Inal JM - Search Results

1

Bernstein DE, Piedad J, Hemsworth L, West A, Johnston ID, Dimov N, Inal JM, Vasdev N. Bernstein DE, et al. Among authors: inal jm. Urol Oncol. 2021 Aug;39(8):455-470. doi: 10.1016/j.urolonc.2021.03.010. Epub 2021 Apr 29. Urol Oncol. 2021. PMID: 33934962 Review.

2

Label-free real-time acoustic sensing of microvesicle release from prostate cancer (PC3) cells using a Quartz Crystal Microbalance.

Stratton D, Lange S, Kholia S, Jorfi S, Antwi-Baffour S, Inal J. Stratton D, et al. Biochem Biophys Res Commun. 2014 Oct 24;453(3):619-24. doi: 10.1016/j.bbrc.2014.09.132. Epub 2014 Oct 6. Biochem Biophys Res Commun. 2014. PMID: 25301562

3

Microvesicles released constitutively from prostate cancer cells differ biochemically and functionally to stimulated microvesicles released through sublytic C5b-9.

Stratton D, Moore C, Antwi-Baffour S, Lange S, Inal J. Stratton D, et al. Biochem Biophys Res Commun. 2015 May 8;460(3):589-95. doi: 10.1016/j.bbrc.2015.03.074. Epub 2015 Mar 24. Biochem Biophys Res Commun. 2015. PMID: 25817790

4

Prostate cancer cells stimulated by calcium-mediated activation of protein kinase C undergo a refractory period before re-releasing calcium-bearing microvesicles.

Stratton D, Moore C, Zheng L, Lange S, Inal J. Stratton D, et al. Biochem Biophys Res Commun. 2015 May 8;460(3):511-7. doi: 10.1016/j.bbrc.2015.03.061. Epub 2015 Mar 19. Biochem Biophys Res Commun. 2015. PMID: 25797625

5

Inhibition of microvesiculation sensitizes prostate cancer cells to chemotherapy and reduces docetaxel dose required to limit tumor growth in vivo.

Jorfi S, Ansa-Addo EA, Kholia S, Stratton D, Valley S, Lange S, Inal J. Jorfi S, et al. Sci Rep. 2015 Aug 25;5:13006. doi: 10.1038/srep13006. Sci Rep. 2015. PMID: 26302712 Free PMC article.

6

Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells.

Kosgodage US, Uysal-Onganer P, MacLatchy A, Mould R, Nunn AV, Guy GW, Kraev I, Chatterton NP, Thomas EL, Inal JM, Bell JD, Lange S. Kosgodage US, et al. Among authors: inal jm. Transl Oncol. 2019 Mar;12(3):513-522. doi: 10.1016/j.tranon.2018.12.004. Epub 2018 Dec 28. Transl Oncol. 2019. PMID: 30597288 Free PMC article.

7

Low Magnetic Field Exposure Alters Prostate Cancer Cell Properties.

Lange S, Inal JM, Kraev I, Dart DA, Uysal-Onganer P. Lange S, et al. Among authors: inal jm. Biology (Basel). 2024 Sep 19;13(9):734. doi: 10.3390/biology13090734. Biology (Basel). 2024. PMID: 39336161 Free PMC article.

8

A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy.

Kholia S, Jorfi S, Thompson PR, Causey CP, Nicholas AP, Inal JM, Lange S. Kholia S, et al. Among authors: inal jm. J Extracell Vesicles. 2015 Jun 19;4:26192. doi: 10.3402/jev.v4.26192. eCollection 2015. J Extracell Vesicles. 2015. PMID: 26095379 Free PMC article.

9

Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy.

De Sousa KP, Rossi I, Abdullahi M, Ramirez MI, Stratton D, Inal JM. De Sousa KP, et al. Among authors: inal jm. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Jan;15(1):e1835. doi: 10.1002/wnan.1835. Epub 2022 Jul 27. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023. PMID: 35898167 Free PMC article. Review.

10

Complement C2 receptor inhibitor trispanning: a novel human complement inhibitory receptor.

Inal JM, Hui KM, Miot S, Lange S, Ramirez MI, Schneider B, Krueger G, Schifferli JA. Inal JM, et al. J Immunol. 2005 Jan 1;174(1):356-66. doi: 10.4049/jimmunol.174.1.356. J Immunol. 2005. PMID: 15611259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters